Other small molecules, including those with action at TrkB [236,237], p75NTR [238], and REST [239] have also shown limited beneficial effects in HD models, likely due in part to the partial rescue of BDNF expression or TrkB activity through their pharmacological targets. Here, NTRK2 is linked to Huntington disease.